In Irritable bowel syndrome Irritable bowel syndrome is a chronic (long-term) inflammatory disease of the large intestine (colon) that usually needs long-term management. This can lead to bleeding, frequent diarrhea, bloating, flatulence, cramps, and stomach pain. Spasmolar Tablet relaxes the muscles in your stomach and gut (intestine) and relieves these symptoms effectively. Usually, it is used along with other medicines for the management of your condition. Continue taking it for as long as the doctor may advise you to. Take a fiber-rich diet, avoid oily or spicy food and drink plenty of fluids while taking it to make sure you stay hydrated.
It is unsafe to consume alcohol with Spasmolar Tablet.
Spasmolar Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Spasmolar Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Spasmolar Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Spasmolar Tablet should be used with caution in patients with kidney disease. Dose adjustment of Spasmolar Tablet may be needed. Please consult your doctor.
Spasmolar Tablet should be used with caution in patients with liver disease. Dose adjustment of Spasmolar Tablet may be needed. Please consult your doctor. However, the use of Spasmolar Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Spasmolar Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More